Burt Wealth Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-77
Closed -$19K – 120
2020
Q4
$19K Hold
77
– – 0.01% 241
2020
Q3
$22K Buy
77
+2
+3% +$558 0.01% 234
2020
Q2
$20K Hold
75
– – 0.01% 230
2020
Q1
$24K Hold
75
– – 0.01% 211
2019
Q4
$22K Hold
75
– – 0.01% 228
2019
Q3
$17K Hold
75
– – 0.01% 253
2019
Q2
$18K Hold
75
– – 0.01% 245
2019
Q1
$18K Hold
75
– – 0.01% 247
2018
Q4
$23K Hold
75
– – 0.01% 224
2018
Q3
$26K Hold
75
– – 0.01% 227
2018
Q2
$22K Hold
75
– – 0.01% 239
2018
Q1
$21K Hold
75
– – 0.01% 248
2017
Q4
$24K Hold
75
– – 0.01% 234
2017
Q3
$23K Sell
75
-230
-75% -$68.1K 0.02% 223
2017
Q2
$82K Buy
305
+230
+307% +$60.8K 0.06% 134
2017
Q1
$21K Hold
75
– – 0.02% 221
2016
Q4
$21K Hold
75
– – 0.02% 228
2016
Q3
$23K Hold
75
– – 0.02% 210
2016
Q2
$18K Hold
75
– – 0.02% 225
2016
Q1
$20K Hold
75
– – 0.02% 245
2015
Q4
$22K Hold
75
– – 0.02% 196
2015
Q3
$21K Hold
75
– – 0.03% 179
2015
Q2
$31K Hold
75
– – 0.03% 172
2015
Q1
$32K Hold
75
– – 0.03% 160
2014
Q4
$25K Buy
+75
New +$24.3K 0.03% 176

Other funds holding BIIB

Burt Wealth Advisors's BIIB Position: Q1 2021 in Review

Burt Wealth Advisors sold out of Biogen (BIIB) in Q1 2021, closing a stake of 77 shares — an estimated $19K sold.

Burt Wealth Advisors first reported a position in BIIB in Q4 2014 and held it in 25 quarters. The position peaked at $82K in Q2 2017. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Burt Wealth Advisors reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Burt Wealth Advisors sold 77 Biogen shares in Q1 2021, an estimated $19K.
  • Burt Wealth Advisors first reported a position in Biogen in Q4 2014 and held it in 25 quarters.
  • Burt Wealth Advisors's Biogen position peaked at $82K in Q2 2017.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Burt Wealth Advisors's 13F filing for Q1 2021, filed 15 Apr 2021.